Amit Meridor - Syneron Medical CEO and Pres
CEO
Mr. Amit Meridor is Chief Executive Officer of Syneron Medical Ltd. Mr. Meridor is a nephew of Shimon Eckhouse, our Chairman of the Board. Prior to his appointment as CEO, he had served as President of the Company since July 1, 2013, with responsibility for a wide range of mandates in the areas of operations, marketing, services and business development. Before joining Syneron, Mr. Meridor served for three years as CEO of Tefron, Ltd., a leading Israeli apparel company During his tenure, Mr. Meridor directed the reorganization of the sales, financial, operational, and manufacturing processes, as well as important strategic business initiatives that returned the company to growth. From 2009 to 2010, Mr. Meridor was CEO of CMT Medical, a medical device company that he successfully restructured and sold to a major European medical technology conglomerate. Mr. Meridors experience also includes a previous tenure at Syneron from 2005 to 2008, where he served as Executive Vice President of International Sales and Business Development since 2014.
| Age | 54 |
| Tenure | 10 years |
| Professional Marks | MBA |
| Phone | 972 73 24 42200 |
| Web | http://www.syneron-candela.com |
Syneron Medical Management Efficiency
The company has return on total asset (ROA) of 1.05 % which means that it generated a profit of $1.05 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.03) %, meaning that it created substantial loss on money invested by shareholders. Syneron Medical's management efficiency ratios could be used to measure how well Syneron Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CEO Age | ||
| Fernando Mora | Compania Cervecerias Unidas | N/A | |
| Jose Nasrallah | Compania Cervecerias Unidas | 58 | |
| Matthew Ouimet | Cedar Fair LP | 62 | |
| Richard Zimmerman | Cedar Fair LP | 63 | |
| Francisco Barriocanal | Compania Cervecerias Unidas | N/A | |
| Alvaro Marambio | Compania Cervecerias Unidas | N/A | |
| Hugo Zalazar | Compania Cervecerias Unidas | N/A | |
| Francisco Mackenna | Compania Cervecerias Unidas | 57 | |
| Stephen Arcos | Compania Cervecerias Unidas | N/A | |
| Fernando Sacchi | Compania Cervecerias Unidas | 59 | |
| Francisco Dominguez | Compania Cervecerias Unidas | 59 | |
| Carlos Diaz | Compania Cervecerias Unidas | N/A | |
| Marco Dallolio | Compania Cervecerias Unidas | N/A | |
| Alvaro Garcia | Compania Cervecerias Unidas | N/A | |
| Pedro Aguado | Compania Cervecerias Unidas | 50 | |
| Alvaro Roman | Compania Cervecerias Unidas | N/A | |
| Matias Subercaseaux | Compania Cervecerias Unidas | N/A | |
| Claudio Melendez | Compania Cervecerias Unidas | N/A | |
| Matias Bebin | Compania Cervecerias Unidas | N/A | |
| James Bernau | Willamette Valley Vineyards | 70 | |
| Claudio Lizana | Compania Cervecerias Unidas | N/A | |
Management Performance
| Return On Equity | -2.03 | |||
| Return On Asset | 1.05 |
Syneron Medical Leadership Team
Elected by the shareholders, the Syneron Medical's board of directors comprises two types of representatives: Syneron Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Syneron. The board's role is to monitor Syneron Medical's management team and ensure that shareholders' interests are well served. Syneron Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Syneron Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Schlachet, Director | ||
| Sarit Soccary, VP of Bus. Devel. and Strategy | ||
| Erik Dowell, President of Aesthetic Division North America | ||
| Ilan Nacasch, Chief Branding Officer | ||
| Dan Suesskind, External Independent Director | ||
| Dominick Arena, Director | ||
| Robert Ruck, Executive Vice President Asia Pacific | ||
| Sarit BenYochanan, Vice President - Business Development & Strategy | ||
| Zack Kubow, IR Contact Officer | ||
| Hugo Goldman, CFO | ||
| Yaffa Krindel, Independent Director | ||
| Robert Fielitz, Managing Director of Europe, Middle East and Africa and Executive VP | ||
| Stephen Fanning, Director | ||
| William Griffing, CEO - Syneron Candela North America | ||
| Yaffa Sieradzki, Independent Director | ||
| Shimon Eckhouse, Co-Founder and Chairman | ||
| Shlomo Alkalay, COO | ||
| Amit Meridor, CEO and Pres | ||
| Michael Anghel, External Independent Director |
Syneron Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Syneron Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.03 | |||
| Return On Asset | 1.05 | |||
| Profit Margin | (1.41) % | |||
| Operating Margin | 1.57 % | |||
| Current Valuation | 219.73 M | |||
| Shares Outstanding | 35.23 M | |||
| Shares Owned By Insiders | 7.43 % | |||
| Shares Owned By Institutions | 73.70 % | |||
| Number Of Shares Shorted | 352.71 K | |||
| Price To Earning | (91.67) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Syneron Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Syneron Medical's short interest history, or implied volatility extrapolated from Syneron Medical options trading.
Pair Trading with Syneron Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Syneron Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syneron Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to AES could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AES when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AES - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The AES to buy it.
The correlation of AES is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AES moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AES moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AES can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Syneron Stock
If you are still planning to invest in Syneron Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneron Medical's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |